Photo of Andrew David Badley

View Scopus Profile

Andrew David Badley, MD

  • 4955 Citations
  • 39 Scopus h-Index
1990 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Andrew David Badley is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
HIV Medicine & Life Sciences
Apoptosis Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
HIV Infections Medicine & Life Sciences
HIV Protease Inhibitors Medicine & Life Sciences
HIV-1 Medicine & Life Sciences
Cell Death Medicine & Life Sciences
Nelfinavir Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1996 2020

Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence.

Badley, A. D.

National Institutes of Health

6/15/15 → 5/31/20

Project: Research project

HIV
Apoptosis
TNF-Related Apoptosis-Inducing Ligand Receptors
HIV Infections
Virus Diseases

Prime shock and kill for HIV erradication

Badley, A. D.

National Institutes of Health

2/15/14 → 1/31/19

Project: Research project

Shock
HIV
T-Lymphocytes
Apoptosis
Human Immunodeficiency Virus Proteins

Enhancing control of HIV by inhibiting TRAILshort

Badley, A. D.

National Institutes of Health

7/2/13 → 6/1/15

Project: Research project

HIV
Natural Killer Cells
HIV Infections
Berlin
Infection

Procaspase 8 Activation by HIV Protease

Badley, A. D.

National Institutes of Health

5/1/04 → 4/30/09

Project: Research project

HIV Protease
Caspase 8
Apoptosis
Human Immunodeficiency Virus Proteins
Mutation

Significance of HIV Protease Cleavage of Procaspase 8

Badley, A. D.

National Institutes of Health

9/1/03 → 8/31/04

Project: Research project

HIV Protease
Caspase 8
Apoptosis
T-Lymphocytes
Infection

Research Output 1990 2019

HIV elite control is associated with reduced TRAILshort expression

Paim, A. C., Cummins, N. W., Natesampillai, S., Garcia-Rivera, E., Kogan, N., Neogi, U., Sönnerborg, A., Sperk, M., Bren, G. D., Deeks, S., Polley, E. & Badley, A. D., Sep 1 2019, In : AIDS. 33, 11, p. 1757-1763 7 p.

Research output: Contribution to journal › Article

HIV-1
HIV
Blood Cells
Cell Death
HIV Infections

Risks and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with HIV Infection

Arslan, S., Litzow, M. R., Cummins, N. W., Rizza, S., Badley, A. D., Navarro, W. & Hashmi, S. K., Jan 1 2019, In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journal › Review article

Hematopoietic Stem Cell Transplantation
Hematologic Neoplasms
HIV Infections
Graft vs Host Disease
Survival

Trailshort protects against CD4 T cell death during acute HIV infection

Natesampillai, S., Paim, A. C., Cummins, N. W., Chandrasekar, A. P., Bren, G. D., Lewin, S. R., Kiem, H. P. & Badley, A. D., Aug 1 2019, In : Journal of Immunology. 203, 3, p. 718-724 7 p.

Research output: Contribution to journal › Article

HIV Infections
Cell Death
T-Lymphocytes
HIV-1
Clustered Regularly Interspaced Short Palindromic Repeats
1 Citation (Scopus)

Translation to Practice: Accelerating the Cycle of Innovation to Impact

Anderson, J. R., Chung, T. D. Y., Clark, L., Weis, J. A., Danielsen, A. J., Khosla, S., Gores, G. J. & Badley, A. D., Jan 1 2019, In : Mayo Clinic proceedings.

Research output: Contribution to journal › Review article

Biological Factors
Practice Guidelines
Physicians
Equipment and Supplies
Pharmaceutical Preparations

Allogeneic stem cell transplantation alone is unlikely to provide the HIV-1 cure

Cummins, N. W. & Badley, A. D., Jan 1 2018, In : Future Virology. 13, 5, p. 307-308 2 p.

Research output: Contribution to journal › Editorial

Stem Cell Transplantation
HIV-1